awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38966308-6EF86B05-48BB-479B-B1CE-66ED263C7181
Q38966308-6EF86B05-48BB-479B-B1CE-66ED263C7181
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38966308-6EF86B05-48BB-479B-B1CE-66ED263C7181
Emerging drugs to reduce abnormal β-amyloid protein in Alzheimer's disease patients.
P2860
Q38966308-6EF86B05-48BB-479B-B1CE-66ED263C7181
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38966308-6EF86B05-48BB-479B-B1CE-66ED263C7181
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e8a970821b95b76b17bb9f78283e66f87a102f99
P2860
Amyloid-directed monoclonal antibodies for the treatment of Alzheimer's disease: the point of no return?